FDX1 and breast cancer: Another vital discovery of our research was that we developed a cuproptosis-related prognostic signature containing six genes (CDKN2A, MTF1, PDHA1, DLD, LIPT1, and FDX1) for breast cancer, which predicted the OS rate with an accuracy that ranged from medium to high.